Drugs / Enzira® Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01857297 | May → Jun 2013 | influenza | Seqirus | Completed | No outcome recorded |
| Phase 4 | NCT01113580 | May 2010 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enzira vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01857297 ↗ |
| Modality | Vaccine | “CSL's 2010/2011 Formulation of Enzira® Vaccine” NCT01113580 ↗ |
| Route | Intramuscular | “administered by intramuscular injection” NCT01113580 ↗ |